Brief: AcuCort Q1 Net Loss Widens To SEK 2.1 Million
April 29 - AcuCort AB ACUC.TE :
* SAID ON TUESDAY Q1 LOSS AFTER TAX SEK 2.1 MLN VS LOSS SEK
1.4
MLN YR AGO
* ESTIMATES NOW COVID-19 IMPACT IS LIMITED
Source text for Eikon: urn:newsml:reuters.com:*:nWkrbrX7fR
Further company coverage: ACUC.TE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))
Recent news on AcuCort AB
See all newsBrief: Acucort Plans To Apply For U.S. Market Approval For Zeqmelit In 2026
Brief: AcuCort Signs Its First Commercial Agreement For Zeqmelit
Brief: Acucort AB Acucort Receives Marketing Authorization For Drug Zeqmelit By Norwegian Medicines Agency
Brief: Acucort Receives Marketing Authorization For The Drug Zeqmelit By The Danish Medicines Agency
Brief: AcuCort Is Granted Sme Status By The European Medicines Agency, EMA